ID
16701
Beschreibung
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Long-Term Follow-Up Assessment
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Stichworte
Versionen (1)
- 01.08.16 01.08.16 -
Hochgeladen am
1. August 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beschreibung
Radiology
Beschreibung
Chest/upper abdomen CT scan
Datentyp
integer
Alias
- UMLS CUI [1]
- C0202823
- UMLS CUI [2]
- C1627748
Beschreibung
Date chest/upper abdomen CT scan
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0202823
- UMLS CUI [2,1]
- C0011008
- UMLS CUI [2,2]
- C1627748
Beschreibung
If relapse was documented, complete Relapse Report and New Lesion Specification page.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0277556
Beschreibung
Radiologic Examination
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0043299
Beschreibung
Date of assessment
Datentyp
date
Alias
- UMLS CUI [1]
- C2985720
Beschreibung
Evaluation Method
Datentyp
text
Alias
- UMLS CUI [1]
- C2911685
Beschreibung
If relapse was documented, complete Relapse Report and New Lesion Specification page.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0277556
Beschreibung
Chest X-ray
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0039985
Beschreibung
Chest CT
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0202823
Beschreibung
CT of the chest/upper abdomen
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0202823
- UMLS CUI [2]
- C1627748
Beschreibung
Long-Term Follow-Up Adverse Events
Beschreibung
Long-Term Follow-Up Adverse Events
Beschreibung
Record only study drug-related events that are ongoing or new.
Datentyp
text
Alias
- UMLS CUI [1]
- C0877248
Beschreibung
Grade severity (1,2,3,4,5) using NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0. A change in CTC grade should be recorded as a separate event.
Datentyp
integer
Alias
- UMLS CUI [1]
- C1710066
Beschreibung
Adverse Event Start Date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697888
Beschreibung
Adverse Event End Date
Datentyp
date
Alias
- UMLS CUI [1]
- C2697886
Beschreibung
If event is serious, complete the SERIOUS ADVERSE EVENT FORM and fax to the appropriate number on the CRF General lnstructions page.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1710056
Ähnliche Modelle
Long-Term Follow-Up Assessment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0750480 (UMLS CUI [1,2])
C1522577 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
C1627748 (UMLS CUI [2])
C0202823 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C1627748 (UMLS CUI [2,2])
C1627748 (UMLS CUI [2])